Literature DB >> 31213430

BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.

Rosemarie Mastropolo1, Allison Close2, Steven W Allen2, Kenneth L McClain3, Scott Maurer2,4, Jennifer Picarsic5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31213430      PMCID： PMC6595264          DOI： 10.1182/bloodadvances.2019000093

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  31 in total

1.  Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases.

Authors:  Dennis P O'Malley; Angie Duong; Todd S Barry; Steve Chen; Michele K Hibbard; Judith A Ferry; Robert P Hasserjian; Mary A Thompson; Mary S Richardson; Ronald Jaffe; Jagmohan S Sidhu; Peter M Banks
Journal:  Mod Pathol       Date:  2010-08-20       Impact factor: 7.842

2.  Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease.

Authors:  Matthias S Matter; Michel Bihl; Darius Juskevicius; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2017-06-09       Impact factor: 4.064

3.  BRAF mutation leading to central nervous system rosai-dorfman disease.

Authors:  Timothy E Richardson; Megan Wachsmann; Dwight Oliver; Zahidur Abedin; Diana Ye; Dennis K Burns; Jack M Raisanen; Benjamin M Greenberg; Kimmo J Hatanpaa
Journal:  Ann Neurol       Date:  2018-08-16       Impact factor: 10.422

4.  Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

Authors:  Sébastien Héritier; Zofia Hélias-Rodzewicz; Hélène Lapillonne; Nathalie Terrones; Sonia Garrigou; Corinne Normand; Mohamed-Aziz Barkaoui; Jean Miron; Geneviève Plat; Nathalie Aladjidi; Anne Pagnier; Anne Deville; Marion Gillibert-Yvert; Despina Moshous; Alain Lefèvre-Utile; Anne Lutun; Catherine Paillard; Caroline Thomas; Eric Jeziorski; Philippe Nizard; Valérie Taly; Jean-François Emile; Jean Donadieu
Journal:  Br J Haematol       Date:  2017-04-25       Impact factor: 6.998

Review 5.  Co-occurrence of intracranial Rosai-Dorfman disease and Langerhans histiocytosis of the skull: case report and review of literature.

Authors:  Shankar Ayyappan Kutty; Sreekala Sreehari
Journal:  Turk Neurosurg       Date:  2015       Impact factor: 1.003

6.  The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.

Authors:  Leomar Y Ballester; Miguel D Cantu; Karen P H Lim; Stephen F Sarabia; Lizmery Suarez Ferguson; C Renee Webb; Carl E Allen; Kenneth L McClain; Carrie A Mohila; Jyotinder N Punia; Angshumoy Roy; Dolores H López-Terrada; M John Hicks; Kevin E Fisher
Journal:  Hematol Oncol       Date:  2017-02-20       Impact factor: 5.271

Review 7.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

8.  Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis.

Authors:  Raphaela Schwentner; Alexandra Kolenová; Gunhild Jug; Thomas Schnöller; Martina Ahlmann; Bernhard Meister; Thomas Lehrnbecher; Milen Minkov; Caroline Hutter
Journal:  Pediatr Res       Date:  2018-11-24       Impact factor: 3.756

9.  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Julien Haroche; Zhan Yao; Jing Ma; Sameer A Parikh; Zhaoming Wang; John Choi; Eunhee Kim; Fleur Cohen-Aubart; Stanley Chun-Wei Lee; Yijun Gao; Jean-Baptiste Micol; Patrick Campbell; Michael P Walsh; Brooke Sylvester; Igor Dolgalev; Olga Aminova; Adriana Heguy; Paul Zappile; Joy Nakitandwe; Chezi Ganzel; James D Dalton; David W Ellison; Juvianee Estrada-Veras; Mario Lacouture; William A Gahl; Philip J Stephens; Vincent A Miller; Jeffrey S Ross; Siraj M Ali; Samuel R Briggs; Omotayo Fasan; Jared Block; Sebastien Héritier; Jean Donadieu; David B Solit; David M Hyman; José Baselga; Filip Janku; Barry S Taylor; Christopher Y Park; Zahir Amoura; Ahmet Dogan; Jean-Francois Emile; Neal Rosen; Tanja A Gruber; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2015-11-13       Impact factor: 39.397

10.  Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.

Authors:  Eli L Diamond; Vivek Subbiah; A Craig Lockhart; Jean-Yves Blay; Igor Puzanov; Ian Chau; Noopur S Raje; Jurgen Wolf; Joseph P Erinjeri; Jean Torrisi; Mario Lacouture; Elena Elez; Ferran Martínez-Valle; Benjamin Durham; Maria E Arcila; Gary Ulaner; Omar Abdel-Wahab; Bethany Pitcher; Martina Makrutzki; Todd Riehl; José Baselga; David M Hyman
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777
View more
  3 in total

1.  Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion.

Authors:  Shaimaa S Eissa; Michael R Clay; Teresa Santiago; Gang Wu; Lu Wang; Barry L Shulkin; Jennifer Picarsic; Kim E Nichols; Patrick K Campbell
Journal:  Blood Adv       Date:  2020-07-14

2.  BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.

Authors:  J Picarsic; T Pysher; H Zhou; M Fluchel; T Pettit; M Whitehead; L F Surrey; B Harding; G Goldstein; Y Fellig; M Weintraub; B C Mobley; P M Sharples; M L Sulis; E L Diamond; R Jaffe; K Shekdar; M Santi
Journal:  Acta Neuropathol Commun       Date:  2019-11-04       Impact factor: 7.801

3.  Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai-Dorfman Disease.

Authors:  Ming Tang; Xue-Zhong Gu; Peng-Chun Wu; Xuan-Tao Yang
Journal:  J Inflamm Res       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.